Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy
Open Access
- 23 February 2007
- journal article
- research article
- Published by Springer Nature in Gastric Cancer
- Vol. 10 (1) , 45-51
- https://doi.org/10.1007/s10120-006-0410-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancerInternational Journal of Cancer, 2005
- The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines.2003
- Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance.2003
- Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells.2002
- Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinomaCancer, 2002
- Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patientsBritish Journal of Cancer, 2002
- Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.2001
- Insulin-Like Growth Factor (IGF) Binding Protein-3 Potentiation of IGF Action Is Mediated through the Phosphatidylinositol-3-Kinase Pathway and Is Associated with Alteration in Protein Kinase B/AKT Sensitivity*Endocrinology, 2000
- Cellular survival: a play in three AktsGenes & Development, 1999
- PI3K: Downstream AKTion Blocks ApoptosisCell, 1997